Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Quantum-Si Inc Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Quarterly results
Docs: "BRANFORD, Conn. -- -- Aug. 7, 2023 -- Quantum-Si Incorporated , The Protein Sequencing Company TM , today announced financial results for the second quarter ended June 30, 2023. Second Quarter Highlights ● Recognized revenue of $205,000 in the second quarter of 2023. Exited the quarter with an order backlog of two Platinum TM instruments. ● Strengthened the Board of Directors with the addition of Scott Mendel and Jack Kenny. ● Since May 2023, strengthened the Executive Management team with the additions of Jeff Keyes as Chief Financial Officer and Johan Denecke as Senior Vice President, Operations ● Published five new applications notes since May 2023 demonstrating the use of Quantum-Si’s next-generation protein sequencing across various applications in support of b..."
07/19/2023 8-K Quarterly results
06/07/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation Agreement, by and between Quantum-Si Incorporated and Claudia Drayton"
05/16/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of the Registrant, as filed with the Secretary of State of the State of Delaware on May 12, 2023"
05/11/2023 8-K Quarterly results
Docs: "GUILFORD, Conn. -- -- May 11, 2023 -- Quantum-Si Incorporated , The Protein Sequencing Company TM , today announced financial results for the first quarter ended March 31, 2023. Recent Highlights ● Revenue was $254,000 on orders of $449,000 in the first quarter of 2023. ● Gross margin was 48.8% in the first quarter of 2023. ● Appointed Jeff Keyes as Chief Financial Officer effective May 15, 2023. ● Strengthened commercial, operations, and development teams with several key executive appointments to help advance commercialization operations. ● Attended Association of Biomolecular Resource Facilities Annual Meeting and exhibited four new application notes. 2023 Financial Outlook ● The Company expects non-GAAP operating expense growth to be approximately fl..."
05/02/2023 8-K Quarterly results
03/15/2023 8-K Other Events  Interactive Data
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
03/06/2023 8-K Quarterly results
03/02/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Petition of Quantum-Si Incorporated Pursuant to 8 Del. C. § 205"
01/30/2023 8-K Cost Associated with Exit or Disposal Activities  Interactive Data
01/12/2023 8-K Regulation FD Disclosure  Interactive Data
01/09/2023 8-K Quarterly results
12/20/2022 8-K Quarterly results
11/07/2022 8-K Quarterly results
Docs: "GUILFORD, Conn. -- -- Nov. 07, 2022 -- Quantum-Si Incorporated , a life sciences company commercializing the first next-generation, single-molecule protein sequencing platform, today announced financial results for the third quarter ending September 30, 2022."
10/04/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "GUILFORD, Conn. -- -- Oct. 4, 2022 -- Quantum-Si Incorporated , a life sciences company commercializing the first next-generation single-molecule protein sequencing platform, today announced the appointment of Jeff Hawkins as Chief Executive Officer. Mr. Hawkins will succeed Dr. Jonathan Rothberg, Founder and Executive Chairman of Quantum-Si, who has also been serving as Interim Chief Executive Officer, and lead the next phase of growth as the Company prepares to launch the Platinum™ instrument, which will be the industry’s first system to enable next generation, single-molecule protein sequencing. This appointment is effective October 10, 2022. “I’m thrilled to welcome Jeff to Quantum-Si. He is a proven business leader and life sciences inventor with decades of experience driving co..."
08/08/2022 8-K Quarterly results
06/16/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
03/08/2022 8-K Quarterly results
02/28/2022 8-K Quarterly results
Docs: "GUILFORD, Conn.-- --Feb. 28, 2022-- Quantum-Si Incorporated , a life sciences company commercializing single molecule protein sequencing, today announced financial results for the fourth quarter and fiscal year ended December 31, 2021. Recent Business Highlights ● Announced the appointment of Dr. Jonathan Rothberg, Founder and Executive Chairman of the Board, as Interim Chief Executive Officer. ● Formed a new Scientific Advisory Board whose goal will be to identify high-impact, routine applications for single molecule protein sequencing across research, clinical, and diagnostics. ● Established list prices for our protein sequencing platform in anticipation of commercial launch in 2022. ● Shared a technical manuscript on bioRxiv providing an overview of Time Domain S..."
02/14/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation Agreement, by and between Quantum-Si Incorporated and John Stark"
01/12/2022 8-K Regulation FD Disclosure  Interactive Data
01/10/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Press Release of Quantum-Si Incorporated"
01/04/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Lease Agreement between Quantum-Si Incorporated and Winchester Office LLC",
"Quantum-Si Signs Lease for New Headquarters in New Haven"
11/10/2021 8-K Quarterly results
Docs: "Press Release"
10/19/2021 8-K Quarterly results
09/29/2021 8-K Quarterly results
09/24/2021 8-K Quarterly results
08/16/2021 8-K Quarterly results
Docs: "Quantum-Si Reports Second Quarter 2021 Financial Results"
07/06/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Quantum-Si Incorporated Executive Severance Plan"
06/25/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy